Single-Dose Safety and Pharmacokinetics of Brecanavir, a Novel Human Immunodeficiency Virus Protease Inhibitor

Benzer Materyaller

• Safety and Pharmacokinetics of Brecanavir, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, following Repeat Administration with and without Ritonavir in Healthy Adult Subjects
  Yazar:: Reddy, Y. Sunila, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral Dosing
  Yazar:: Sadler, Brian M., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Safety and Pharmacokinetics of GSK364735, a Human Immunodeficiency Virus Type 1 Integrase Inhibitor, following Single and Repeated Administration in Healthy Adult Subjects
  Yazar:: Reddy, Y. Sunila, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Pharmacokinetic Study of Human Immunodeficiency Virus Protease Inhibitors Used in Combination with Amprenavir
  Yazar:: Sadler, Brian M., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects with Normal or Impaired Hepatic Function
  Yazar:: Veronese, Laurence, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)